Chargement en cours...
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Natalizumab, a humanized anti-α4 integrin monoclonal antibody, is a highly effective treatment approved for MS. An association between MS and an exposure to Epstein-Barr Virus (EBV) sustained by the l...
Enregistré dans:
| Publié dans: | Dis Markers |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4460255/ https://ncbi.nlm.nih.gov/pubmed/26101453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/901312 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|